Selective cell cycle arrest in glioblastoma cell lines by quantum molecular resonance alone or in combination with temozolomide

BACKGROUND: Glioblastoma is the most aggressive form of brain cancer, characterised by high proliferation rates and cell invasiveness. Despite advances in surgery and radio-chemotherapy, patients continue to have poor prognoses, with a survival rate of 14–15 months. Thus, new therapeutic strategies...

Descripción completa

Detalles Bibliográficos
Autores principales: Catanzaro, Daniela, Milani, Gloria, Bozza, Angela, Bernardi, Martina, Chieregato, Katia, Menarin, Martina, Merlo, Anna, Celli, Paola, Belli, Romina, Peroni, Daniele, Pozzato, Alessandro, Pozzato, Gianantonio, Raneri, Fabio Angelo, Volpin, Lorenzo, Ruggeri, Marco, Astori, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427848/
https://www.ncbi.nlm.nih.gov/pubmed/35715634
http://dx.doi.org/10.1038/s41416-022-01865-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427848/
https://www.ncbi.nlm.nih.gov/pubmed/35715634
http://dx.doi.org/10.1038/s41416-022-01865-9

Ejemplares similares